Company Background

HCV-TARGET

Formed in 2015, Target RWE was created as an outcome of the success of HCV-TARGET, a case study of the Target RWE Model for hepatitis C. HCV-TARGET was a partnership between academia, the FDA and industry established in 2011 by Michael W. Fried, MD, FAASLD and David R. Nelson, MD. To date, the study has enrolled over 14,000+ patients across 60 sites in North America and Europe.

The evidence from HCV-TARGET has been utilized by regulators to monitor post-marketing drug safety, and by sponsors to support label expansion and mitigate phase IV commitments. In late 2018, Dr. Fried and members of the HCV-TARGET team were awarded the Civilian Honor Award for Regulatory Science Excellence by the FDA “for outstanding public-private partnership leveraging real-world evidence.” 

The HCV-TARGET case study has helped inform national and international treatment guidelines and was used in payer dossiers. As a result, numerous high impact scientific presentations and manuscripts were published. To date, the study generated a total of 9 publications and 30+ abstract presentations. The proven success of the HCV-TARGET model and platform was the basis of Target RWE's foundation in 2015 and its expansion into various disease indications. 

At a glance

  • Headquartered in Durham, NC
  • Multi-Sources for Data Capturing
  • 600+ Network Sites 
  • 100,000+ Patients
  • 8 Disease-Specific Registries
  • 40+ Publications
  • 70+ Expert Authors

Company Timeline

November 2011

stacked books

HCV-TARGET Study

February 2015

stacked books

TARGET PharmaSolutions founded

July 2016

stacked books

Launched NASH community

October 2016

stacked books

Launched PBC community

January 2017

stacked books

Launched HCC community

July 2017

stacked books

Launched IBD community

November 2017

stacked books

Executed CRADA with FDA

January 2018

stacked books

Site expansion in Europe

August 2018

stacked books

Launched HBV community

January 2019

stacked books

Launched DERM community

January 2020

stacked books

New CEO Announced

February 2020

stacked books

Launched ASTHMA community

April 2020

stacked books

Launched COVID-19 community

April 2020

stacked books

Launched COVID-19 EHR Database

August 2020

stacked books

Company renamed to Target RWE